v3.26.3
Unaudited Condensed Consolidated Statements of Cash Flows - USD ($)
9 Months Ended
Sep. 30, 2026
Sep. 30, 2025
Cash flows from operating activities:    
Net loss $ (21,586,816) $ (4,845,845)
Adjustments to reconcile net loss to net cash used in operating activities:    
Stock-based compensation 218,325 234,727
Stock-based compensation — common stock grants 1,700,000
Advisory shares committed for issuance 8,113,318
Depreciation and amortization 40,324 1,721
Change in fair value of derivative liability (604,683) (22,377)
Non-cash interest 1,212,398 27,554
Accretion of debt discounts 3,805,715 39,833
Unrealized (gain) loss from changes in fair value of digital assets 9,993,209
Realized gain and trading gains on digital assets (2,011,847)
Digital assets received as yield income (701,630)
Proceeds from sales of digital assets, net of purchases 182,166
Gain on deconsolidation of subsidiary (7,803,653)
Change in fair value of equity securities 710,705
Changes in operating assets and liabilities:    
Accounts receivable (2,480,000)
Prepaid expenses and other current assets 108,192 (2,219,630)
Accounts payable and accrued expenses 2,858,403 (23,558)
Operating lease liability (7,636)
Net cash used in operating activities (7,953,510) (5,107,575)
Cash flows from investing activities:    
Redemption of short-term investments 2,000,000
Purchases of property and equipment (9,394) (35,909)
Cash of subsidiary derecognized upon deconsolidation (53,186)
Net cash provided by (used in) investing activities 1,937,420 (35,909)
Cash flows from financing activities:    
Proceeds from notes payable, net of original issue discount 5,970,000 12,203,046
Payment of debt issuance costs (585,000)
Repayment of notes payable (1,000,000)
Cash advances from (repayments to) related parties 11,345 (76,400)
Proceeds from subscription receivable on subsidiary shares 1,002
Net cash provided by financing activities 4,397,347 12,126,646
Net change in cash, cash equivalents and restricted cash (1,618,743) 6,983,162
Cash, cash equivalents and restricted cash, beginning of period 9,636,655 3,455
Cash, cash equivalents and restricted cash, end of period 8,017,912 6,986,617
Supplemental disclosure of cash flow information:    
Cash paid for interest 160,000
Cash paid for income taxes
Non-cash investing and financing activities:    
Debt issuance costs accrued in connection with notes payable 280,000
Common stock issued in settlement of shares committed for issuance 4,477,056
Conversion of convertible notes into common stock 429,317
Equity securities received on deconsolidation of subsidiary 962,935
Reconciliation of cash, cash equivalents and restricted cash:    
Unrestricted cash and cash equivalents 17,912 6,986,617
Restricted cash 8,000,000
Total cash, cash equivalents and restricted cash $ 8,017,912 $ 6,986,617